Tau, prions and Aβ: the triad of neurodegeneration

Acta Neuropathol. 2011 Jan;121(1):5-20. doi: 10.1007/s00401-010-0691-0. Epub 2010 May 16.

Abstract

This article highlights the features that connect prion diseases with other cerebral amyloidoses and how these relate to neurodegeneration, with focus on tau phosphorylation. It also discusses similarities between prion disease and Alzheimer's disease: mechanisms of amyloid formation, neurotoxicity, pathways involved in triggering tau phosphorylation, links to cell cycle pathways and neuronal apoptosis. We review previous evidence of prion diseases triggering hyperphosphorylation of tau, and complement these findings with cases from our collection of genetic, sporadic and transmitted forms of prion diseases. This includes the novel finding that tau phosphorylation consistently occurs in sporadic CJD, in the absence of amyloid plaques.

Publication types

  • Review

MeSH terms

  • Amyloid beta-Peptides / genetics
  • Amyloid beta-Peptides / physiology*
  • Animals
  • Cell Cycle / genetics
  • Cell Cycle / physiology
  • Cell Death / genetics
  • Cell Death / physiology
  • Humans
  • Neurodegenerative Diseases / etiology
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / pathology*
  • Phosphorylation / genetics
  • Phosphorylation / physiology
  • Prions / genetics
  • Prions / pathogenicity
  • Prions / physiology*
  • tau Proteins / genetics
  • tau Proteins / metabolism*
  • tau Proteins / physiology

Substances

  • Amyloid beta-Peptides
  • Prions
  • tau Proteins